RO7502175
- Generic Name
- RO7502175
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 450
- Registration Number
- NCT05581004
- Locations
- 🇪🇸
Hospital Universitario 12 De Octubre, Madrid, Spain
🇪🇸Hospital Universitario Virgen de la Victoria, Malaga, Spain
🇪🇸Hospital Clinico Universitario de Valencia, Valencia, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath